CMTM6 and cancer: PD-L1 expression was present with 12 samples (28.5%) from 8 types of cancers, while negative with the other 11 types of cancers (Table 1), PD-L1 positive samples are all positive with CMTM6 expression, none of CMTM6 negative samples have positivity for PD-L1 expression.